BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 38663915)

  • 1. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
    Chen M; Liu H; Hong B; Xiao Y; Qian Y
    FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of tumor-associated macrophages and M2 macrophages in CRC: unraveling molecular heterogeneity and developing a novel risk signature.
    Shi L; Mao H; Ma J
    BMC Med Genomics; 2024 May; 17(1):145. PubMed ID: 38802881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
    Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
    J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating single-cell RNA-sequencing and bulk RNA-sequencing data to explore the role of mitophagy-related genes in prostate cancer.
    Liu ZY; Huang RH
    Heliyon; 2024 May; 10(9):e30766. PubMed ID: 38774081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers.
    Liu H; Sima X; Xiao B; Gulizeba H; Zhao S; Zhou T; Huang Y
    J Transl Med; 2024 May; 22(1):486. PubMed ID: 38773508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
    Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Li Z; Chen Z; Shi W; Xu Y; Huang Z; Lin Z; Dou R; Lin S; Jiang X; Li M; Jiang S
    Aging (Albany NY); 2024 Apr; 16(8):6809-6838. PubMed ID: 38663915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness.
    Li X; Zheng C; Xue X; Wu J; Li F; Song D; Li X
    Funct Integr Genomics; 2023 Apr; 23(2):115. PubMed ID: 37010617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
    Lin S; Dai Y; Han C; Han T; Zhao L; Wu R; Liu J; Zhang B; Huang N; Liu Y; Lai S; Shi J; Wang Y; Lou M; Xie J; Cheng Y; Tang H; Yao H; Fang H; Zhang Y; Wu X; Shen L; Ye Y; Xue L; Wu ZB
    Genome Med; 2024 Apr; 16(1):60. PubMed ID: 38658971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular Communication-Related Molecular Subtypes and a Gene Signature Identified by the Single-Cell RNA Sequencing Combined with a Transcriptomic Analysis.
    Guan P; Cai W; Wu K; Jiang F; Wu J; Zhai X; Zeng M
    Dis Markers; 2022; 2022():6837849. PubMed ID: 35620271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporaneous and upcoming trends in immunotherapy for prostate cancer: review.
    Saleem S; Rashid AB; Shehzadi S; Mumtaz H; Saqib M; Bseiso A; Villasenor AV; Ahmed A; Sonia SN
    Ann Med Surg (Lond); 2023 Aug; 85(8):4005-4014. PubMed ID: 37554896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma.
    Su Y; Xue C; Gu X; Wang W; Sun Y; Zhang R; Li L
    Front Oncol; 2023; 13():1176572. PubMed ID: 37305578
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.